GSK and Regeneron to mine gene data from 500000 Britons

March 23, 2017 | Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease. Reuters